Leading the way to safer medication
 Crosscheck  Recommender

DESFERAL Sterile, lyophilised powder (2017)

Active ingredients: Deferoxamine

Product Name and Form

Desferal Vials, 500mg or 2g.

Pharmaceutical form

A sterile, lyophilised powder available in vials containing 500mg or 2g of desferrioxamine mesilate.

Qualitative and Quantitative Composition

Each vial contains desferrioxamine mesilate 500mg or 2g.

Chemical substance
Description
Deferoxamine

Deferoxamine is a chelating agent for trivalent iron and aluminium ions. The resulting chelates are stable and non-toxic.

List of excipients

None present.

Pack sizes and Marketing

Each vial contains a white to practically white lyophilisate supplied in a clear glass vial in a pack size of 10 (500 mg) or 1 (2 g).

Marketing authorization holder
Authorization dates

Novartis Pharmaceuticals UK Limited

Trading as: Ciba Laboratories, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR

31 October 1997 / 12 December 2000

Marketing authorization number:

PL 00101/0523